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To date there is ample evidence that patients with vitiligo accumulate millimolar concentrations of hydrogen
peroxide (H2O2) in their epidermis as well as in their blood lymphocytes/monocytes. Several enzymes are affected
by this H2O2 including catalase, glutathione peroxidase, and 4a-carbinolamine dehydratase. The latter enzyme
disrupts the recycling of the essential cofactor (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin (6BH4) for the aromatic
amino acid hydroxylases as well as the nitric oxide synthases. In this report we have elucidated the inﬂuence of
H2O2 on dihydropteridine reductase (DHPR), the last enzyme in the 6BH4-recycling process. Here we show for the
ﬁrst time that concentrations of less than 30 lM H2O2 increase DHPR activities, whereas levels greater than 30 lM
H2O2 deactivate the enzyme based on the oxidation of Met
146 and Met151 in the sequence, consequently leading to
disruption of the NADH-dependent enzyme active site. This oxidation was conﬁrmed by Fourier transform-Raman
spectroscopy yielding the expected SO band at 1025 cm1 characteristic of methionine sulfoxide. Hence these
results unmasked a novel regulatory mechanism for DHPR enzyme activity. Moreover, we also demonstrated that
DHPR activities in whole blood of patients with vitiligo are signiﬁcantly decreased in untreated patients, whereas
activities are normalized after removal of epidermal H2O2 with a topical pseudocatalase (PC-KUS). Taken together,
these new data add more evidence to a systemic involvement of H2O2 in the pathomechanism of vitiligo.
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Vitiligo is an acquired depigmentation disorder affecting
0.5% to 2% of the world population (Ortonne and Bose,
1993). The etiology is still unknown (Ortonne and Bose,
1993). Recently it has been shown in vivo and in vitro that
patients with vitiligo accumulate high levels (mM) of
hydrogen peroxide (H2O2) in their epidermis (Schallreuter
et al, 1999, 2001). In the past, several sources for this
unusual epidermal H2O2 production/accumulation have
been documented (Passi et al, 1998; Schallreuter et al,
1991, 1994b, 1996, 1999; Rokos et al, 2002). Moreover, it is
also well established that millimolar levels of H2O2 lead to
the inactivation of catalase and in this context it is
noteworthy that low epidermal as well as systemic catalase
levels have indeed been described in this patient group
(Aronoff, 1965; Schallreuter et al, 1991; Dell’Anna et al,
2001). In addition it has been shown that glutathione
peroxidase (EC 1.11.1.9) activities are also decreased
(Beazley et al, 1999). Table I summarizes the sources of
H2O2 documented to date in vitiligo.
The clinical hallmark of vitiligo is the loss of the inherited
skin color in association with a characteristic fluorescence
under Wood’s light (351 nm) examination (Schallreuter et al,
1994b). This fluorescence has been attributed to the
accumulation of 6- and 7-biopterin as well as to the
formation of pterin-6-carboxylic acid via H2O2 oxidation
(Schallreuter et al, 1994b; Rokos et al, 2002). Moreover, it
was shown that the epidermal de novo synthesis/recycling/
regulation of the essential cofactor (6R)-L-erytho-5,6,7,8-
tetrahydrobiopterin (6BH4) is perturbed in vitiligo (Schall-
reuter et al, 1994b, 2001). Here it is noteworthy that 6BH4 is
the immediate electron donor for the hydroxylation of
the aromatic amino acids L-phenylalanine, L-tyrosine, and
L-tryptophan (Nagatsu et al, 1964; Kaufman and Fisher,
1974; Kaufman, 1997). Both epidermal melanocytes and
keratinocytes hold the full capacity for autocrine 6BH4 de
novo synthesis/recycling and regulation (Schallreuter et al,
1994b, c, 2001). Figure 1 presents a simplified scheme for
the de novo synthesis/recycling/regulation of this cofactor
with its impaired metabolic steps in vitiligo.
In this context it was realized that the epidermal 6BH4 de
novo synthesis in patients with vitiligo is highly activated,
whereas the recycling is slowed down owing to low or
absent pterin-4a-carbinolamine dehydratase (PCD, EC
4.2.1.96; synonyms 4a-OH-tetrahydrobiopterin dehydra-
Abbreviations: 6BH4, (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin;
DHPR, dihydropteridine reductase; FT, Fourier transform; H2O2,
hydrogen peroxide; PAH, phenylalanine hydroxylase; PCD, pterin-
4a-carbinolamine dehydratase.
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tase, dimerization cofactor of hepatocyte nuclear factor 1)
activities in association with the formation of the 7-isomer
(7BH4) (Schallreuter et al, 1994c, 2001; Tho¨ny et al, 2000).
Earlier it was shown that this 7-isomer is a potent inhibitor of
phenylalanine hydroxylase (PAH, EC 1.14.16.1) activities
(Davis et al, 1992; Kowlessur et al, 1996) and decreased
epidermal PAH activities in association with increased
phenylalanine levels were indeed detected in vitro in suction
blister material and by in vivo Fourier transform (FT)-Raman
spectroscopy on the skin of patients with vitiligo (Schall-
reuter et al, 1994b, 1998). In this context it is also important
that the production of 7BH4 not only uncouples the PAH
reaction but also leads to the generation of H2O2 and
quinonoid dihydropterin instead of L-tyrosine (Kowlessur
et al, 1996) (see Fig 1). Moreover, it was shown that PCD
protein expression as well as enzyme activities are directly
Table I. Conﬁrmed sources for epidermal/systemic H2O2 generation/accumulation in vitiligo
a
Source (reference) H2O2 generation/ accumulation Change
Monoamine oxidase A (Schallreuter et al, 1996) E "
NADPH oxidase (Schallreuter et al, 1999) E "
Photooxidation of pterins (Rokos et al, 2002) E "
Nitric oxide synthases (Gibson and Lilley, 1997) E "
Short circuit in the 6BH4 recycling (Schallreuter et al, 1994b; Kaufman, 1997) E "
Catalase (Dell’Anna et al, 2001; Schallreuter et al, 1991; Maresca et al, 1997) B,E #
Glutathione peroxidase/glutathione (Beazley et al, 1999; Dell’Anna et al, 2001) B #
Tyrosinase-related protein 1 (Jimbow et al, 2001) E #
a " , increased; # , decreased; E, in epidermis; B, in blood.
Figure 1
De novo synthesis/recycling/regulation of 6BH4 in the production of L-tyrosine as a substrate for melanogenesis and catecholamine
synthesis. Both epidermal keratinocytes and melanocytes hold the full capacity for autocrine de novo synthesis/recycling and regulation of 6BH4
(Schallreuter et al, 1994b, c). Guanosine triphosphate (GTP) serves as a substrate for de novo synthesis where guanosine triphosphate
cyclohydrolase I (GTP-CH I) is the rate-limiting step. 6BH4 acts as a cofactor for the hydroxylation of the aromatic amino acids L-phenylalanine via
PAH and L-tyrosine via tyrosine hydroxylase (TH) (Kaufman, 1997). TH is the rate-limiting enzyme for catecholamine synthesis in keratinocytes
(Schallreuter et al, 1992) and melanocytes.1 Only recently it has been shown that TH forms L-DOPA for activation of tyrosinase in melanocytes
(Marles et al, 2003). PAH produces 4a-carbinolamine as an intermediate in the recycling process of 6BH4, which is dehydrated by PCD to quinonoid
dihydropterin followed by the NADH-dependent reduction via DHPR to 6BH4. In addition, 6BH4 de novo synthesis is controlled by GTP-CH I
feedback regulatory protein (GFRP), which upregulates GTP-CH I after binding of L-phenylalanine, whereas 6BH4 binding exerts the opposite effect.
During the recycling the 7-isomer 7BH4 is nonenzymatically formed from 4a-carbinolamine. This isomer inhibits PAH as observed in untreated vitiligo
(Davis et al, 1992; Schallreuter et al, 1994c; Kowlessur et al, 1996) ( " upregulation; and # downregulation in the epidermis of patients with vitiligo).
1Gillbro JM, Marles LK, Schallreuter KU: Autocrine catecholamine
synthesis and the expression of b2-adrenoceptors in human
melanocytes. Pigment Cell Res 15(Suppl 9):82, 2002 (abstr.).
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affected by H2O2 (Schallreuter et al, 2001). After removal of
epidermal H2O2 with a low-dose narrow-band ultraviolet B-
activated pseudocatalase (PC-KUS) enzyme activities as
well as protein expression returned to normal concomitant
with decreased 7BH4 levels (Schallreuter et al, 2001).
Nevertheless, PAH activities were not affected.
A close examination of the entire amino acid sequence of
PCD yielded four candidates for H2O2 oxidation. It was then
demonstrated that oxidation of only one Trp residue in
position 24 changed the binding of the substrate 4a-
carbinolamine drastically, leading to enzyme deactivation
(Schallreuter et al, 2001). Based on these observations, we
here asked whether the last step in 6BH4 recycling via
dihydropteridine reductase (DHPR, EC 1.6.99.7) could also
be affected by H2O2. For this purpose we used purified
DHPR and we showed that enzyme activities are signifi-
cantly decreased in the presence of concentrations of
greater than 30 mM H2O2, whereas concentrations of less
than 30 mM yielded increased activities. To gain more insight
into the effect of H2O2 on the enzyme, we utilized
Hyperchem computer modeling based on the crystal
structure published by Varughese et al (1992, 1994) which
identified Met146 and Met151 in the sequence as possible
oxidation candidates leading to deactivation of the enzyme
by direct interference with the NADH cofactor binding. This
result was confirmed by FT-Raman spectroscopy and
amino acid analysis demonstrating the presence of methio-
nine sulfoxide after exposure of DHPR to H2O2 (10
3 M). In
summary, these results unmasked a novel regulatory
mechanism by H2O2 in the control of DHPR enzyme
activities. Because the presence of DHPR enzyme activities
is well documented in peripheral lymphocytes, erythrocytes,
leukocytes, and platelets (Firgaira et al, 1979, 1981;
Narisawa et al, 1980, 1981), we used whole blood from
untreated/treated patients with vitiligo and healthy controls
to explore the possible contribution of systemic H2O2 stress
by following DHPR activities in these patients. Our results
demonstrated indeed significantly decreased enzyme activ-
ities in untreated patients, whereas after removal of
epidermal H2O2 with a low-dose narrow-band ultraviolet B
activated pseudocatalase (PC-KUS) systemic DHPR activ-
ities returned to normal. These results provide further
evidence to the contribution of systemic H2O2 stress in
the pathomechanism of vitiligo.
Results
mRNA of DHPR is expressed in epidermal melanocytes
and keratinocytes and in white blood cells The presence
of DHPR mRNA was shown by RT-PCR in human epidermal
melanocytes and keratinocytes as well as in lymphocytes
and monocytes (Fig 2).
DHPR enzyme activities are regulated by H2O2 To
examine the effect of H2O2 on DHPR activities in more
detail, we used purified sheep liver DHPR and tested the
influence of various H2O2 concentrations. The results
showed a concentration-dependent regulation of DHPR
activities. In the presence of 10 and 20 mM H2O2, the Vmax of
DHPR is significantly increased compared to Vmax in the
absence of H2O2 (Fig 3a). Nevertheless, in the presence of
30 mM H2O2 the Vmax starts to decrease. Upon further
increase of H2O2 concentrations the Vmax decreases
exponentially (Fig 3b). These results suggested either
deactivation of the enzyme or uncompetitive inhibition.
Figure2
DHPR expression in human epidermal melanocytes and keratino-
cytes and in white blood cells (lymphocytes/monocytes). RT-PCR
for DHPR mRNA in human epidermal keratinocytes (lane 3), melano-
cytes (lane 4), and lymphocytes/monocytes (lane 5). The primer pair
amplifies a sequence of 206 bp, which is in agreement with the
expected product. The product was separated in a 1.5% agarose gel
(lane 1, 100-bp ladder; lane 2, negative control).
Figure3
The influence of H2O2 on the Vmax of DHPR activity. Enzyme
activities were determined in the presence of H2O2 in the range of 10 to
80 mm. (a) Increase of Vmax for DHPR with H2O2 concentrations of less
than 30 mm. (b) Decrease of Vmax for DHPR with H2O2 concentrations of
greater than 30 mm. The decrease of Vmax suggests deactivation of the
enzyme. N.B., Vmax without the addition of H2O2 is 4.76 mU.
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Computer modeling supports methionine oxidation
resulting in deactivation of the enzyme To gain more
insight into the possible mechanism of enzyme deactiva-
tion/uncompetitive inhibition, we utilized computer model-
ing. The DeepView computer model allows an excellent
view into the structure of the active site helix of human
DHPR and reveals insights into the mechanism of enzyme
deactivation. Figure 4a presents the DHPR active site
structure in its native form. Within the helix there are two
residues, Tyr149 and Lys153, playing a vital role for the
transfer of the proton from NADH to quinonoid dihydropter-
in. Only two residues, Met146 and Met151, which are
potential candidates for H2O2 oxidation, are in close vicinity
to the NADH-binding site. The oxidation to methionine
sulfoxide of these two residues yields a conformational
change of the helix. In addition the oxidation causes a
spatial shift of the helix away from the cofactor NADH (Fig
4b). These changes of the active-site helix result in a
disrupted proton transfer followed by deactivation of the
enzyme. These results suggest deactivation rather than
uncompetitive inhibition. The remaining five other Met
residues in the enzyme structure do not affect the active
site after oxidation.
H2O2 oxidation of Met residues in DHPR supports
deactivation of the enzyme To prove the computer
prediction of DHPR deactivation by H2O2 oxidation of
Met146 and Met153, we utilized FT-Raman spectroscopy (Fig
5) and amino acid analysis. The expected oxidation product
was methionine sulfoxide, which leads to the well-assigned
SO stretch at 1025 cm1. As expected the spectrum of
native DHPR did not show this SO stretch, whereas after
oxidation of the enzyme with H2O2 (10
3 M), the spectrum
yielded the appearance of the expected peak. This result
was confirmed by the solid methionine sulfoxide standard
(Fig 5). In addition, the formation of methionine sulfoxide
was confirmed by amino acid analysis. There was no Met
detectable after oxidation, implicating that all seven Met
residues were oxidized (data not shown). Based on these
results we can conclude that methionines in the protein
structure of DHPR are indeed oxidized by H2O2.
DHPR activity is reduced in whole blood of patients with
untreated vitiligo DHPR activities in blood cells were
determined by several investigators (Firgaira et al, 1979,
1981; Narisawa et al, 1980, 1981). Moreover, involvement of
systemic oxidative stress has been suggested in vitiligo
(Beazley et al, 1999; Dell’Anna et al, 2001). Therefore, we
tested DHPR activities in whole-blood samples of these
patients before and after removal of epidermal H2O2 with
low-dose narrow-band ultraviolet B-activated pseudocata-
lase (PC-KUS) and compared them to healthy controls (Fig
6). Patients without treatment had significantly (po0.0001)
decreased DHPR activities compared to healthy controls.
Nevertheless, surprisingly DHPR activities in blood cells
recovered after removal of epidermal H2O2.
Discussion
To date there is a plethora of evidence that the human
epidermis holds the capacity for catecholamine synthesis/
degradation/signal transduction and this pathway is under
tight feedback by the cofactor 6BH4 via both PAH to
produce L-tyrosine and tyrosine hydroxylase to initiate the
rate-limiting step in catecholamine biosynthesis (Schallreu-
ter et al, 1994b, c, 1995a). Moreover, recently the presence
of the serotoninergic pathway, where tryptophan hydro-
xylase (EC 1.14.16.4) is also controlled by 6BH4, has been
demonstrated in the human epidermis (Friedman et al,
1972; Slominski and Wortsman, 2000; Slominski et al,
2002). In addition there is compelling evidence for the
presence of the nitric oxide synthases in the human
epidermis, which also require the same cofactor (Shimizu
et al, 1997). Hence, the presence of an autocrine 6BH4
de novo synthesis/recycling/regulation in epidermal kerati-
nocytes and melanocytes was an important discovery to
understand and investigate in more depth the above-
Figure4
DeepView of the short-chain helix of
the active site of DHPR. (a) Native
enzyme: the helix of the enzyme with the
location of Lys153, Tyr149, Met146, and
Met151 indicated by arrows. (b) H2O2-
oxidized enzyme: a conformational
change occurs owing to the oxidation
of Met146 and Met151 to methionine
sulfoxide affecting the orientation of
Tyr149 and Lys153. This shift disrupts
the integrity of the catalytic center.
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mentioned pathways in the epidermal compartment (Schall-
reuter et al, 1994b, c, 2001). In this context the regulation of
the rate-limiting step in the recycling of 6BH4 via PCD by
H2O2 was a pioneering breakthrough (Schallreuter et al,
2001). Moreover, it was of great value to realize that this
reactive oxygen species can oxidize 6BH4 to 6-biopterin as
well as to pterin-6-carboxylic acid (Moore et al, 2002; Rokos
et al, 2002). Both metabolites are under certain conditions
cytotoxic to melanocytes (Schallreuter et al, 1994a). In this
report, we asked whether the last step in the recycling of
6BH4 via DHPR would also be affected by H2O2. The results
of this study have unmasked a novel general mechanism in
control of DHPR enzyme regulation. In this context it is
important to note that DHPR belongs to a rare group of
short-chain helix dehydrogenases where the short helix is
involved in NADH binding (Varughese et al, 1992, 1994).
Based on the X-ray structure of DHPR it has been shown
that the two residues, Lys153 and Tyr149, are involved in the
formation of the functioning NADH-binding domain where
Tyr149 is implicated in catalysis vis-a-vis proton transfer
(Varughese et al, 1994).
The oxidation of native DHPR by 103 M H2O2, as shown
in this report, involves the formation of methionine sulfoxide.
This oxidation of Met146 and Met151 in the sequence of the
short-chain helix causes a spatial alteration in the NADH-
binding domain (Fig 4b). Consequently Tyr149 is moved to
a position where proton transfer cannot take place. Hence
the enzyme is deactivated. The presence of methionine
sulfoxide in H2O2-oxidized DHPR was indeed confirmed by
FT-Raman spectroscopy yielding a characteristic SO
stretch at 1025 cm1 (Fig 5) and by amino acid analysis
(data not shown).
Furthermore, we have also demonstrated additional
evidence for the contribution of systemic H2O2-induced
stress by following DHPR activities in whole blood of
patients with vitiligo (Fig 6). The latter result clearly
strengthened earlier reports by Picardo’s group, who
showed low levels of catalase in whole-blood lymphocytes
and mitochondrial alterations based on oxidative stress in
these patients, and by Beazley et al, who documented
decreased systemic glutathione peroxidase activities in this
patient group (Maresca et al, 1997; Beazley et al, 1999;
Dell’Anna et al, 2001). Taken together, it appears that
patients with vitiligo have to combat H2O2 not only in their
epidermis but also in the vascular system. Nevertheless,
there seems to be a much higher accumulation of H2O2 in
the millimolar range in the epidermal compartment as
shown in vitro and in vivo compared to the systemic
contribution which is in the micromolar range (Schallreuter
et al, 1999, 2001). Unfortunately the determination of H2O2
in the micromolar range is below the detection limits of FT-
Raman spectroscopy. Our results presented herein together
with the earlier documentation on the control of PCD
enzyme activity by H2O2 prove that the entire 6BH4
recycling process is severely affected in vitiligo (Schallreuter
et al, 1994b, c, 2001). At this point it is noteworthy that
these patients benefit from removal of epidermal H2O2 with
a pseudocatalase (PC-KUS) in association with repigmen-
tation of the depigmented areas (Schallreuter et al, 1999;
Schallreuter et al, 1995b, 2001, 2002a, b). Nevertheless, the
results of this study indicated for the first time that the
removal of epidermal H2O2 clearly affects the systemic
H2O2 balance in the patients since DHPR enzyme activities
in whole blood return to normal after topical treatment. This
observation clearly implicates H2O2 transfer between the
avascular epidermis and the vascular system. Taking into
consideration that the results of this study showed that
35  106 M H2O2 inhibits in vitro pure DHPR activities as
observed in the analysis of the total blood samples of
untreated patients at the same level, we can conclude that
the transfer of epidermal H2O2 to the vascular system
involves a concentration decrease from 103 to 106 M.
Based on our data we suggest that H2O2 may be a major
Figure 5
FT-Raman spectrum of native DHPR/H2O2-oxidized DHPR com-
pared to methionine sulfoxide. Arrow, the formation of methionine
sulfoxide based on the appearance of the SO stretch at 1025 cm1,
which is not detectable in native enzyme. (    ) Native DHPR; (???)
oxidized DHPR; (—) methionine sulfoxide standard. N.B. The standard
shows in addition the presence of methionine sulfone owing to an
impurity of the supplied compound. This result was also confirmed by
amino acid analysis. There is no sulfone present in H2O2-oxidized
DHPR.
Figure 6
DHPR activities in whole-blood cells of patients with vitiligo before
and after treatment with topical pseudocatalase (PC-KUS). DHPR
activities (mU/mg hemoglobin) were determined in whole blood of
healthy controls (n¼10), untreated patients (n¼ 27), and treated
patients with vitiligo (n¼ 10) as outlined under Materials and Methods.
The result shows that DHPR activities are significantly reduced before
treatment and recovered in whole blood after removal of H2O2 with
pseudocatalase PC-KUS (po0.0001).
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player in the proposed immune/autoimmune reaction in
vitiligo. To substantiate this possible link further, work is
under way.
Materials and Methods
Patients and controls Whole-blood samples were collected from
untreated patients with vitiligo vulgaris of skin phototype II/III
(Fitzpatrick classification) (n¼ 27) (Fitzpatrick et al, 1971) and after
treatment (n¼ 10) with low-dose narrow-band ultraviolet B-
activated pseudocatalase (PC-KUS) according to the published
protocol (Schallreuter et al, 1995b, 1999, 2002a, b). The group of
untreated patients included 12 men and 15 women with a mean
age of 35.1 y (range 14–69 y). Within the group of treated patients
there were 6 women and 4 men with a mean age of 46.3 y (range
33–65 y). Controls were 4 women and 6 men with a mean age of
36.3 y (range 20–51 y). The study was approved by the local ethics
committee and in agreement with the Helsinki Declaration Principles.
Cell culture of epidermal keratinocytes and melanocytes Hu-
man normal melanocytes were established from breast skin or
foreskin in MCDB 153 medium using the method of Pittelkow and
Shipley (1989). Keratinocytes were established in serum-free
MCDB 153 medium using the method of Wille et al (1984). Cultures
were grown to confluence, and cells were harvested in the third to
fourth passages.
RT-PCR in epidermal keratinocytes/melanocytes and white
blood cells Total RNA was isolated from cultured human
keratinocytes and melanocytes using the Ambion Totally RNA
isolation kit (Ambion Inc., Austin, TX). Quality of RNA was assessed
by measuring the ratio A260/A280 and in a 1% agarose gel
electrophoresis using 1  Tris-borate-ethylenediaminetetraacetate
buffer. cDNA was synthesized using the reverse transcription
system (Promega, Southampton, UK). Reaction mix contained
approximately 1 mg of total RNA and 500 pmol of oligo(dT) primer in
a final volume of 20 mL. For PCR amplification 2 mL cDNA was used
in a final volume of 50 mL containing 10  PCR buffer (200 mM
Tris-HCl, pH 8.4, 500 mM KCl; Life Technologies, Paisley, UK), 1
mmol dNTP (10 mM each of the four nucleotides; Promega), 50
nmol MgCl2 (Life Technologies), 1 pmol of each primer, and 2.5
units of recombinant Taq DNA polymerase (Life Technologies).
PCR was performed with 1 min 951C, 1 min 581C decreasing 0.11C
per cycle, and 1 min 721C for 35 cycles. A 206-bp fragment of the
DHPR sequence (GenBank Accession No. AB053170) was
amplified using primers with the following sequence: forward
50-GCTGCAGGCGAGGCGCG-30 and reverse 50-GAGCTTTC-
CAACCTCAGCAGT-30.
Whole blood was centrifuged in a Lymphoprep (Axis-Shield
PocAS, Oslo, Norway) density gradient to isolate mononuclear
cells (lymphocytes and monocytes). Total RNA was isolated using
TRI REAGENT (Sigma, Dorset, UK) and processed as described
above.
Analysis of DHPR activities DHPR activities were determined by
the method of Hasegawa and Nakanishi (1987). For the whole-
blood analysis the modified procedure by Arai et al (1982) was
used.
Briefly, whole-blood samples were blotted on filter paper, air-
dried, and stored at –201C for up to 2 mo until further use. The
assay included the extraction of the dried blood in 0.15 M KCl for
30 min at room temperature. The hemolysate was centrifuged at
9000 g, and an aliquot of the supernatant was used for the assay.
The final reaction mixture contained 50 mM Tris buffer (pH 7.6), 1
mM cytochrome c (Sigma), 2 mM NADH (Sigma), and 40 mL of
sample in a volume of 1 mL. After a 5 min preincubation at 251C,
10 mL of 1 mM 6-methyltetrahydropterin solution (Schircks, Jona,
Switzerland) was added to the cuvette followed by mixing. The
reaction was spectrophotometrically determined at 550 nm based
on the formation of reduced cytochrome c. The latter is formed as
a result of the 6-methyltetrahydropterin oxidation to quinonoid
dihydropterin by cytochrome c where subsequently quinonoid
dihydropterin is reduced to 6BH4 by DHPR. Enzyme activities (mU)
were standardized per milligram hemoglobin. Examination of the
effect of H2O2 on DHPR activity was performed using purified
sheep liver DHPR (Sigma) in the presence and absence of different
H2O2 concentrations.
FT-Raman spectroscopy FT-Raman spectra were acquired using
a Bruker RFS 100/S spectrometer with a liquid-nitrogen-cooled
Germanium detector. Near-infrared excitation was produced by a
Nd3þ :YAG laser operating at 1064 nm. Each spectrum was
accumulated over 17 min with 1000 scans and a resolution of
4 cm1. DHPR samples were lyophilized and measured as solids.
The SO stretch was visualized as a peak at 1025 cm1. This peak
was confirmed with solid methionine sulfoxide as standard (Sigma).
Computer modeling The structural model of native and H2O2-
oxidized DHPR in aqueous solution was created and minimized
using DeepView and HyperChem software. For this purpose all
seven Met residues of the published structure were oxidized to see
whether the structural changes affected the active site of the
enzyme (Varughese et al, 1992, 1994).
Statistical analysis For statistical analysis of the data the Mann–
Whitney U test was utilized.
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